Oxford University Press

SHERPA: Yellow

People

  1. Cercek Hanjis
    Cercek Hanjis
  2. Shia
    Shia
  3. Stadler
    Stadler
  4. Berger
    Berger
  5. Ku
    Ku
  6. O'Reilly
    O'Reilly
  7. Selenica
    Selenica
  8. Yaeger
    Yaeger
  9. Birsoy
    Birsoy
  10. Janjigian
    Janjigian

Groups

  1. GME, Medicine (42)
  2. Graduate Medical Education (42)
  3. Department of Medicine (36)
  4. Solid Tumor Oncology Division (33)
  5. Hematology-Oncology Fellows (27)
  6. Center for Pancreatic Cancer Research (18)
  7. GSK Faculty (17)
  8. Gastrointestinal Oncology Service (17)
  9. Human Oncology and Pathogenesis Program (15)
  10. Epidemiology and Biostatistics (13)
Search Within
  1. "GME, Medicine"
Formats
  1. Meeting Abstract (22)
  2. Journal Article (15)
  3. Editorial (3)
  4. Correspondence (1)
  5. Research Letter (1)
Groups
  1. GME, Medicine (42)
  2. Graduate Medical Education (42)
  3. Department of Medicine (36)
  4. Solid Tumor Oncology Division (33)
  5. Hematology-Oncology Fellows (27)
  6. Center for Pancreatic Cancer Research (18)

More Groups

People
  1. Melissa Lumish (7)
  2. Michael Berger (7)
  3. Andrea Cercek Hanjis (6)
  4. Jinru Shia (6)
  5. Yelena Janjigian (6)
  6. Zsofia Stadler (6)

More People

Years
  1. 2024 (3)
  2. 2023 (16)
  3. 2022 (12)
  4. 2021 (9)
  5. 2020 (1)
  6. 2013 (1)
Publications
  1. Annals of Oncology (26)
  2. JNCI: Journal of the National Cancer Institute (4)
  3. The Oncologist (3)
  4. Glycobiology (2)
  5. JNCI Cancer Spectrum (2)
  6. Clinical Infectious Diseases (1)

More Publications

Results (42)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinical and molecular characteristics of early-onset vs average-onset esophagogastric cancer
    Journal Article

    Lumish, M. A.; Walch, H.; Maron, S. B.; Chatila, W.; Kemel, Y.; Maio, A.; Ku, G. Y.; Ilson, D. H.; Won, E.; Li, J.; more...
    JNCI: Journal of the National Cancer Institute (2024)

    Fulltext@MSK | Save
  • POSing the question: MARIPOSA-2, do the ends justify the means?
    Editorial

    Chen, M. F.; Piotrowska, Z.; Yu, H. A.
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Prevalence of enteric infections in patients on immune checkpoint inhibitors and impact on management and outcomes
    Journal Article

    Magahis, P. T.; Satish, D.; Babady, N. E.; Kamboj, M.; Postow, M. A.; Laszkowska, M.; Faleck, D. M.
    The Oncologist (2024)

    Fulltext@MSK | Save
  • Targeting altered glycosylation for broad cancer detection
    Meeting Abstract

    Kudelka, M. R.; Gu, W.; Matsumoto, Y.; Ju, T.; Barnes, R. H. 2nd; Kardish, R. J.; Heimburg-Molinaro, J.; Lehoux, S.; Zeng, J.; Cohen, C.; more...
    Glycobiology (2023)

    Fulltext@MSK | Save
  • Genomic characteristics and clinical outcomes of stereotactic radiosurgery for colorectal cancer brain metastases
    Meeting Abstract

    Gui, C.; Walch, H.; Mueller, K.; Eichholz, J.; Khatri, I.; Del Balzo, L.; Kemeny, N.; Imber, B.; Schultz, N.; Foote, M.; more...
    Neuro-Oncology (2023)

    Fulltext@MSK | Save
  • Efficacy and safety of commercially approved BCMAtargeting CAR-T therapy in triple-class refractory multiple myeloma
    Meeting Abstract

    Nishimura, N.; Brown, S.; Sean, M. D.; Parastoo, D.; Heather, J. L.; Oscar, B. L.; Michael, S.; Gunjan, L. S.; David, J. C.; Hani, H.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • PD-1 blockade as curative intent therapy in mismatch repair deficient locally advanced rectal cancer
    Meeting Abstract

    Cercek, A.; Lumish, M.; Sinopoli, J.; Weiss, J.; Shia, J.; Stadler, Z.; Yaeger, R.; Smith, J. J.; Saltz, L.; Widmar, M.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • CDC7 inhibition constrains lineage plasticity and prevents resistance and neuroendocrine transformation in the lung and prostate
    Meeting Abstract

    Quintanal-Villalonga, Á.; Zaidi, S.; Karthaus, W. R.; Zhan, Y. A.; Shafer, M.; Qiu, J.; de Stanchina, E.; Haffner, M. C.; Sawyers, C. L.; Rudin, C. M.
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • Pan-cancer assessment of the impact of intronic variants on cancer development and progression
    Meeting Abstract

    Safonov, A.; Mehine, M.; Ceyhan-Birsoy, O.; Brown, D.; Bandlamudi, C.; Forbes, A.; Gazzo, A.; Selenica, P.; Shen, R.; Khurana, E.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • Interim results from a phase I/II study of HPN328, a tri-specific, half-life (T1/2) extended DLL3-targeting T cell engager in patients (pts) with small cell lung cancer (SCLC) and other neuroendocrine neoplasms (NEN)
    Meeting Abstract

    Choudhury, N.; Jain, P.; Dowlati, A.; Thompson, J.; Johnson, M. L.; Mamdani, H.; Sanborn, R. E.; Schenk, E. L.; Aggarwal, R.; Sankar, K.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save